Related references
Note: Only part of the references are listed.Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years
Richard A. Walsh et al.
BRAIN (2013)
Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy
C. Lungu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia
Olga Waln et al.
MOVEMENT DISORDERS (2013)
Yips and other movement disorders in golfers
Samish Dhungana et al.
MOVEMENT DISORDERS (2013)
Alleviation of abnormal synaptic neurotransmitter release by cell-permeable form of the truncated SNAP-25 upon transcutaneous delivery
Tae-Yoon Park et al.
NEUROSCIENCE LETTERS (2013)
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Mark Hallett et al.
TOXICON (2013)
Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia
Juan Ramirez-Castaneda et al.
TOXINS (2013)
Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications
Joohi Jimenez-Shahed et al.
EXPERT OPINION ON ORPHAN DRUGS (2013)
Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy
Jennifer Friedman et al.
ANNALS OF NEUROLOGY (2012)
Clinical Relevance of Botulinum Toxin Immunogenicity
Reiner Benecke
BIODRUGS (2012)
Efficacy, Tolerability, and Immunogenicity of OnabotulinumtoxinA in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia
David Charles et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Botulinum Toxin for the Treatment of Movement Disorders
Mary Ann Thenganatt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Emerging therapies for Parkinson's disease
Werner Poewe et al.
CURRENT OPINION IN NEUROLOGY (2012)
Efficacy of botulinum toxins on bruxism: an evidence-based review
Hu Long et al.
INTERNATIONAL DENTAL JOURNAL (2012)
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial
Jens Volkmann et al.
LANCET NEUROLOGY (2012)
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial
Robert Chinnapongse et al.
MOVEMENT DISORDERS (2012)
Pisa syndrome in Parkinson's disease: Clinical, electromyographic, and radiological characterization
Cristina Tassorelli et al.
MOVEMENT DISORDERS (2012)
Status dystonicus: Predictors of outcome and progression patterns of underlying disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2012)
Iron dysregulation in movement disorders
Petr Dusek et al.
NEUROBIOLOGY OF DISEASE (2012)
Retrospective evaluation of the dose equivalence of Botox® and Dysport® in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story
Anna Rita Bentivoglio et al.
NEUROLOGICAL SCIENCES (2012)
Psychiatric disorders in rapid-onset dystonia-parkinsonism
Allison Brashear et al.
NEUROLOGY (2012)
GABAB receptors Structure, functions, and clinical implications
Eduardo E. Benarroch
NEUROLOGY (2012)
Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review
Carlo Colosimo et al.
NEUROTOXICITY RESEARCH (2012)
Muscle selection for treatment of cervical dystonia with botulinum toxin - A systematic review
S. W. R. Nijmeijer et al.
PARKINSONISM & RELATED DISORDERS (2012)
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease
Jonathan W. Dickerson et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2012)
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE)
Joseph Jankovic et al.
BMC NEUROLOGY (2011)
Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia
Daniel Velasco-Sanchez et al.
CEREBELLUM (2011)
Convergent mechanisms in etiologically-diverse dystonias
Valerie B. Thompson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
Joseph Jankovic et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Terminology for Preparations of Botulinum Neurotoxins What a Difference a Name Makes
Alberto Albanese
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm
Bettina Wabbels et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Iron chelation and neuroprotection in neurodegenerative diseases
Xuping Li et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study
Pierre Burbaud et al.
JOURNAL OF NEUROLOGY (2011)
Efficacy of Laryngeal Botulinum Toxin Injection: Comparison of Two Techniques
Susan L. Fulmer et al.
LARYNGOSCOPE (2011)
The Association of Tourette Syndrome and Dopa-Responsive Dystonia
Toby C. Yaltho et al.
MOVEMENT DISORDERS (2011)
The Many Faces of Hemifacial Spasm: Differential Diagnosis of Unilateral Facial Spasms
Toby C. Yaltho et al.
MOVEMENT DISORDERS (2011)
Long-Term Follow-up of Botulinum Toxin Therapy for Focal Hand Dystonia: Outcome at 10 Years or More
Codrin Lungu et al.
MOVEMENT DISORDERS (2011)
Efficacy and Safety of IncobotulinumtoxinA (NT 201, Xeomin) in the Treatment of Blepharospasm-A Randomized Trial
Joseph Jankovic et al.
MOVEMENT DISORDERS (2011)
Iron-Related MRI Images in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deferiprone: Results of a Phase II Pilot Trial
Giovanna Zorzi et al.
MOVEMENT DISORDERS (2011)
AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled Trials
Daniela Berg et al.
MOVEMENT DISORDERS (2011)
The neural substrates of rapid-onset Dystonia-Parkinsonism
D. Paola Calderon et al.
NATURE NEUROSCIENCE (2011)
Whole-Genome Sequencing for Optimized Patient Management
Matthew N. Bainbridge et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia
Kapil D. Sethi et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trial
C. Zadikoff et al.
BASAL GANGLIA (2011)
Camptocormia, Head Drop and Other Bent Spine Syndromes: Heterogeneous Etiology and Pathogenesis of Parkinsonian Deformities
Joseph Jankovic
MOVEMENT DISORDERS (2010)
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia
Fabienne Clot et al.
BRAIN (2009)
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients
I. Trender-Gerhard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Treatment of hyperkinetic movement disorders
Joseph Jankovic
LANCET NEUROLOGY (2009)
Relationship Between Various Clinical Outcome Assessments in Patients with Blepharospasm
Joseph Jankovic et al.
MOVEMENT DISORDERS (2009)
Deep Brain Stimulation in Acute Management of Status Dystonicus
Robert Jech et al.
MOVEMENT DISORDERS (2009)
Paramedical Treatment in Primary Dystonia: A Systematic Review
Catherine C. S. Delnooz et al.
MOVEMENT DISORDERS (2009)
Peripherally Induced Movement Disorders
Joseph Jankovic
NEUROLOGIC CLINICS (2009)
Disease-oriented approach to botulinum toxin use
Joseph Jankovic
TOXICON (2009)
Focal hand dystonia, mirror dystonia and motor overflow
Orapom Sitburana et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay
Mitchell F. Brin et al.
MOVEMENT DISORDERS (2008)
Motor Re-Training Does Not Need to Be Task Specific to Improve Writer's Cramp
Kirsten E. Zeuner et al.
MOVEMENT DISORDERS (2008)
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson et al.
NEUROLOGY (2008)
Noninvasive brain stimulation for Parkinson's disease and dystonia
Allan D. Wu et al.
NEUROTHERAPEUTICS (2008)
Efficacy and safety of purified botulinum toxin type A (Dysport (R)) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial
Daniel Truong et al.
PARKINSONISM & RELATED DISORDERS (2008)
Management of status dystonicus:: Our experience and review of the literature
Paolo Mariotti et al.
MOVEMENT DISORDERS (2007)
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia
J. Jankovic et al.
NEUROLOGY (2006)
Botulinum toxin injection for congenital muscular torticollis presenting in children and adults
Abigail Collins et al.
NEUROLOGY (2006)
Cervical dystonia responsive to acoustic and galvanic vestibular stimulation
Sally M. Rosengren et al.
MOVEMENT DISORDERS (2006)
Familial dopa-responsive cervical dystonia
SA Schneider et al.
NEUROLOGY (2006)
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia
CL Comella et al.
NEUROLOGY (2005)
A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders
SJ Frucht et al.
MOVEMENT DISORDERS (2005)
Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial
R Tintner et al.
NEUROLOGY (2005)
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study
D Truong et al.
MOVEMENT DISORDERS (2005)
TENS for the treatment of writer's cramp dystonia: A randomized, placebo-controlled study
M Tinazzi et al.
NEUROLOGY (2005)
Botulinum toxin injections in the treatment of musician's dystonia
S Schuele et al.
NEUROLOGY (2005)
Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: A case series
NN Byl et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2003)
Sensory training as treatment for focal hand dystonia: A 1-year follow-up
KE Zeuner et al.
MOVEMENT DISORDERS (2003)
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure
D Dressler et al.
JOURNAL OF NEUROLOGY (2003)
Intrathecal baclofen for stiff-person syndrome: Life-threatening intermittent catheter leakage
J Bardutzky et al.
NEUROLOGY (2003)
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
J Jankovic et al.
NEUROLOGY (2003)
Sensorimotor integration in movement disorders
G Abbruzzese et al.
MOVEMENT DISORDERS (2003)
Movement disorders in Friedreich's ataxia
JGG Hou et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm
P Opal et al.
MOVEMENT DISORDERS (2002)
Hand orthosis as a writing aid in writer's cramp
N Tas et al.
MOVEMENT DISORDERS (2001)
Intrathecal baclofen for dystonia
JGG Hou et al.
MOVEMENT DISORDERS (2001)
Intrathecal baclofen for generalized dystonia
AL Albright et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2001)
The long-term response to levodopa in dopa-responsive dystonia
WJ Hwang et al.
PARKINSONISM & RELATED DISORDERS (2001)
Dopa-responsive dystonia:: Mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa
D Steinberger et al.
NEUROLOGY (2000)
Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy
BJ Van Hilten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Mexiletine in the treatment of torticollis and generalized dystonia
C Lucetti et al.
CLINICAL NEUROPHARMACOLOGY (2000)
Treating severe bruxism with botulinum toxin
EK Tan et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2000)
Share Paper
